Back

Off-label dosing of non-vitamin K antagonist oral anticoagulants and adverse outcomes in the daily practice

27 August 2018 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Atrial fibrillation - Stroke prevention 3 Oral Anticoagulation ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Tze-Fan Chao

Taipei Veterans General Hospital, Taipei (Taiwan)

9 More presentations in this session

Presentation thumbnail
Doctor G. Yoon (Incheon, KR)
Abstract
Presentation thumbnail
Professor C. Coleman (Storrs, US)
Abstract Slides
Presentation thumbnail
Doctor M. Ruiz Ortiz (Cordoba, ES)
Abstract Slides
Presentation thumbnail
Assistant Professor Y. Kim (GangNeung, KR)
Abstract Slides
Presentation thumbnail
Doctor C. Lee (Copenhagen, DK)
Abstract

Access the full session

Session thumbnail
Poster Session 5 - Atrial fibrillation - Stroke prevention 3

The Event

Event poster

ESC Congress 2018

27 August 2018 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Prevalence and risk of DOACs inappropriate dosing in atrial fibrillation. An analysis of the Swiss-AF and BEAT-AF registries
1 September 2019
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
19 July 2023
thumbnail
Congress Presentation
Impact of Real-world Off-label dose of Apixaban on long-term clinical outcomes in Atrial Fibrillation patients with Heart failure and Chronic Kidney Disease
1 April 2025
thumbnail
Congress Presentation
Real-world insights on anticoagulation therapies in non-valvular atrial fibrillation: a comprehensive electronic health record-based study using natural language processing and machine learning
7 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources